Outcomes of Eltrombopag Treatment and Development of Iron Deficiency in Children with Immune Thrombocytopenia in Turkey

Ayça Koca Yozgat Goksel Leblebisatan Sinan Akbayram Simge Çınar ÖzelZeynep KarakaşErol ErduranŞebnem YılmazÜlker KoçakŞule ÜnalGül Nihal ÖzdemirMeryem Albayrak Emine Zengin Yeşim Oymak Ozcan Bor Hasan Fatih Cakmakli Yeşim Aydınok Dilek Gürlek Gökçebay Hüseyin Tokgöz Baris MalboraSerap KaramanTülin Tiraje Celkanİlgen ŞaşmazHüsniye Neşe Yaralı Hale Ören Ayşegül Ünüvar Namık Yaşar Özbek

Published in: Turkish journal of haematology : official journal of Turkish Society of Haematology (2020)

Results of the current study imply that EPAG is an effective therapeutic option in pediatric patients with acute refractory and chronic ITP. However, patients must be closely monitored for response and side effects during treatment, and especially for iron deficiency.

Keyphrases

iron deficiency
end stage renal disease
newly diagnosed
chronic kidney disease
young adults
prognostic factors
metabolic syndrome
adipose tissue
combination therapy